 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Advances in the management of diabetic kidney disease: beyond sodium-glucose co-transporter 2 inhibitors |
| Anthony T. P. Chan, Sydney C. W. Tang |
|
Kidney Res Clin Pract. 2022;41(6):682-698. Published online July 19, 2022 DOI: https://doi.org/10.23876/j.krcp.21.285 |
|
Advances in the management of diabetic kidney disease: beyond sodium-glucose co-transporter 2 inhibitors Kidney Research and Clinical Practice. 2022;41(6):682-698  MON-304 Effect of Sodium-Glucose Co-transporter 2 Inhibitors in Patients with Diabetic Kidney Disease Kidney International Reports. 2019;4(7):S424 Sodium–glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering? Kidney International. 2014;86(4):693-700 Renoprotective mechanisms of sodium‐glucose co‐transporter 2 (SGLT2) inhibitors against the progression of diabetic kidney disease Journal of Cellular Physiology. 2021;237(2):1182-1205 Sodium-glucose co-transporter-2 inhibitors in heart failure and chronic kidney disease: the role of empagliflozin Russian Journal of Cardiology. 2021;26:4349 Sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes International Journal of Clinical Practice. 2008;62(8):1279-1284 POS-822 SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS (SGLT2i); SHORT-TERM OUTCOME IN DIABETIC KIDNEY TRANSPLANT RECIPIENTS Kidney International Reports. 2022;7(2):S354 Editorial: Sodium Glucose Co-Transporter 2 Inhibitors and Kidney Function Frontiers in Pharmacology. 2022;13: LBODP041 Effects Of Sodium-glucose Co-transporter 2 Inhibitors (sglt-2 Inhibitors) On Adipokines And Inflammatory Biomarkers In Type2 Diabetic Patients Journal of the Endocrine Society. 2022;6(Supplement_1):A268-A268 Health Expenditure Comparison of Diabetic Patients on Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Vs Dipeptidyl Peptidase-4 (DPP4) Inhibitors Value in Health. 2018;21:S71 |
